ADO 0.00% 2.1¢ anteotech ltd

DCN - Clinical Study, page-13

  1. 105 Posts.
    Hi. Can someone please elaborate or answer some of these points? As they seem like basic due dilligence issues that any potential investor would need answered before progressing to investment stage. (I can't find the answers either).
 
watchlist Created with Sketch. Add ADO (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.